Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome

<p><strong>Background</strong> Transformation of B-cell chronic lymphocytic leukaemia (B-CLL) to diffuse large B cell lymphoma (DLBCL) (Richter’s syndrome (RS)) is a rare (2-15% of patients) but catastrophic complication of B-CLL. Dose-intense chemotherapy regimens investigated in...

Full description

Bibliographic Details
Main Authors: Eyre, TA, Clifford, R, Roberts, C, Boyle, L, Francis, A, Schuh, A, Dutton, S
Format: Journal article
Language:English
Published: BioMed Central 2015

Similar Items

Similar Items